Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392

Watchlist Manager
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Logo
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Watchlist
Price: 73.17 CNY 1.96% Market Closed
Market Cap: 92.5B CNY
Have any thoughts about
Beijing Wantai Biological Pharmacy Enterprise Co Ltd?
Write Note

Relative Value

The Relative Value of one Beijing Wantai Biological Pharmacy Enterprise Co Ltd stock under the Base Case scenario is 81.69 CNY. Compared to the current market price of 73.17 CNY, Beijing Wantai Biological Pharmacy Enterprise Co Ltd is Undervalued by 10%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
81.69 CNY
Undervaluation 10%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
8
vs Industry
27
Median 3Y
17.2
Median 5Y
17.8
Industry
7.7
Forward
35.3
vs History
vs Industry
0
Median 3Y
33.9
Median 5Y
36.1
Industry
22.7
Forward
222.2
vs History
29
vs Industry
3
Median 3Y
46.1
Median 5Y
60
Industry
21.6
vs History
vs Industry
2
Median 3Y
68.9
Median 5Y
129.2
Industry
25.2
vs History
64
vs Industry
11
Median 3Y
9.8
Median 5Y
13
Industry
2.5
vs History
8
vs Industry
25
Median 3Y
16.2
Median 5Y
17.4
Industry
7.7
Forward
33.3
vs History
7
vs Industry
18
Median 3Y
19.5
Median 5Y
20
Industry
9
vs History
vs Industry
2
Median 3Y
24.7
Median 5Y
27.7
Industry
4.2
Forward
115.2
vs History
vs Industry
2
Median 3Y
24.7
Median 5Y
27.7
Industry
4.1
Forward
176.2
vs History
31
vs Industry
3
Median 3Y
43.3
Median 5Y
56.5
Industry
5.7
vs History
vs Industry
2
Median 3Y
64.6
Median 5Y
158.1
Industry
3.6
vs History
64
vs Industry
22
Median 3Y
12.1
Median 5Y
16.9
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Beijing Wantai Biological Pharmacy Enterprise Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
92.8B CNY 37.3 -315.6 -160.5 -160.5
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD 10.9 -241.6 24 25.2
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 6 17.8 16.2 18
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.5 -129.9 -104.6 -76.2
P/E Multiple
Earnings Growth
CN
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Average P/E: 208.3
Negative Multiple: -315.6
164%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -241.6
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Average EV/EBITDA: 17.2
Negative Multiple: -160.5
207%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.2
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.6 N/A
EV/EBIT Multiple
EBIT Growth
CN
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Average EV/EBIT: 22.5
Negative Multiple: -160.5
61%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.2 N/A

See Also

Discover More
Back to Top